KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT (2016 - 2025)

Historic EBT for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $156.8 million.

  • Medpace Holdings' EBT rose 1714.27% to $156.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $542.4 million, marking a year-over-year increase of 1396.34%. This contributed to the annual value of $542.4 million for FY2025, which is 1396.34% up from last year.
  • As of Q4 2025, Medpace Holdings' EBT stood at $156.8 million, which was up 1714.27% from $142.8 million recorded in Q3 2025.
  • Medpace Holdings' 5-year EBT high stood at $156.8 million for Q4 2025, and its period low was $42.7 million during Q2 2021.
  • In the last 5 years, Medpace Holdings' EBT had a median value of $84.6 million in 2023 and averaged $91.9 million.
  • Per our database at Business Quant, Medpace Holdings' EBT surged by 4961.27% in 2022 and then surged by 159.84% in 2023.
  • Quarter analysis of 5 years shows Medpace Holdings' EBT stood at $55.9 million in 2021, then skyrocketed by 31.69% to $73.6 million in 2022, then increased by 23.17% to $90.7 million in 2023, then soared by 47.6% to $133.9 million in 2024, then rose by 17.14% to $156.8 million in 2025.
  • Its EBT stands at $156.8 million for Q4 2025, versus $142.8 million for Q3 2025 and $124.5 million for Q2 2025.